Neuroendocrine regulatory peptide-1 and -2 (NERPs) inhibit the excitability of magnocellular neurosecretory cells in the hypothalamus.

Neuroendocrine regulatory peptide (NERP)-1 and NERP-2 (NERPs) are novel carboxy-terminally amidated peptides derived from the neurosecretory protein VGF. NERPs are colocalized with vasopressin in the paraventricular nucleus (PVN) and the supraoptic nucleus (SON) of the hypothalamus, and suppress vasopressin secretion evoked by intracerebroventricular administration of angiotensin II (AngII) and hypertonic saline or bath administration of AngII. Magnocellular neurosecretory cells (MCNs) of the hypothalamus release vasopressin and oxytocin from their dendrites and soma. The two cell types have common electrophysiological properties in response to glutamate and AngII. We investigated the mechanisms underlying the suppressive effects of NERPs on MCNs. Microdialysis of the PVN demonstrated that NERPs suppressed glutamate release induced by AngII. A whole-cell patch-clamp study of the SON showed that NERPs suppressed the potentiation of excitatory postsynaptic currents (EPSCs) evoked by AngII without affecting the amplitude, indicating that NERPs suppressed EPSCs by a presynaptic mechanism. The suppressive effect of NERP-2, but not NERP-1, was blunted in the presence of tetrodotoxin and bicuculline, a γ-aminobutyric acid (GABA) A receptor antagonist. These results indicate that NERP-1 suppresses presynaptic glutamatergic neurons connected to MNCs, whereas NERP-2 activates GABAergic interneurons, which suppress presynaptic glutamatergic neurons; thus, both peptides suppress vasopressin release. This study demonstrates that NERPs function as inhibitory modulators of vasopressin release.